Recaticimab (Anti-PCSK9)

CAT: 0957-A3023-01Size: 1 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0957-A3023-01Size:1 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Recaticimab (Anti-PCSK9) is a humanized monoclonal antibody that targets PCSK9. It has potential application in hypercholesterolemia. MW :148.28 KD

CAS Number

174722-31-7

Synonyms

SHR-1209

Storage Conditions

Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Related Products

Catalog	Name
A2789-1mg*25	Anti-PCSK9 (Boehringer anti-PCSK9)
A2789-1mg*5	Anti-PCSK9 (Boehringer anti-PCSK9)
A2789-1mg	Anti-PCSK9 (Boehringer anti-PCSK9)
A2789-01	Anti-PCSK9 (Boehringer anti-PCSK9)
A3024-01	Anti-PCSK9 (RG7652)
A2987-01	Ongericimab (Anti-PCSK9)
A2924-1mg*5	Lodelcizumab (Anti-PCSK9)
A3022-1mg*5	Ralpancizumab (Anti-PCSK9)
A3022-1mg	Ralpancizumab (Anti-PCSK9)
A2876-1mg	Frovocimab (Anti-PCSK9)

Catalog	Name
C00749-1mg*25	Recaticimab (Anti-PCSK9)
F1458-1	Anti-PCSK9 Antibody (Recaticimab)
MBS1881609-01	Anti-PCSK9 (recaticimab biosimilar) mAb
047923	PCSK9 (recaticimab) discontinued
M00085-6	Anti-PCSK9 Reference Antibody (recaticimab)
GTR18315628	PCSK9 Reference Antibody (recaticimab)
MBS1881610-01	Biotinylated Anti-PCSK9 (recaticimab biosimilar) mAb
GTR18594897-01	Recaticimab Biosimilar (PCSK9 Reference Antibody)
PX-TA1709-01	Recaticimab Biosimilar - Anti-PCSK9 mAb - Research Grade
MBS1881611-01	PE-conjugated Anti-PCSK9 (recaticimab biosimilar) mAb